What are the key challenges in anticancer drug development, and how might they be addressed? The past three decades have seen spectacular advances in our understanding of the molecular and ...

Medicare Part D, an optional component of Medicare, helps beneficiaries pay for generic and name-brand prescription drugs.  A ...